Target intelligence / Profile preview

Nucleoporin 43kDa pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

ENSG00000251473, also known as "Nucleoporin 43kDa pseudogene" or "LOC100288146," refers to a pseudogene related to the NUP43 gene, which encodes a component of the nuclear pore complex. As a pseudogene, it does not encode a functional protein and is not considered a valid therapeutic target or involved in known molecular functions, disease associations, or drug interactions[4][2]. The true NUP43 gene participates in nuclear-cytoplasmic transport as a genuine nucleoporin, but this entry is a non-functional pseudogene.

Other names
LOC100288146NUP43 pseudogene

Beyond the preview

Go deeper on Nucleoporin 43kDa pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleoporin 43kDa pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call